DRIO - DarioHealth Corp. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

DRIO

DARIOHEALTH CORP.

NASDAQ

$6.77

▼ DOWN 0.00% (-0.00)

KEY STATISTICS

Market Cap$49.50 M

52w High$17.74

52w Low$5.84

Dividend Yield—

Frequency—

P/E-1.16

Volume17.90K

Shares Out.7.31M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Erez Raphael

COMPENSATION 2026

Salary$448,293

Stock Awards$1,344,000

Incentive Plan Pay$0

All Other Comp.$169,791

Total$1,962,084

ABOUT

SECTOR

Healthcare

WENT PUBLIC

March 14, 2016

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

163

PRICE TARGET

Target High$16.00

Target Low$7.50

Target Median$14.00

Target Consensus$12.50

UPCOMING EARNINGS

DateNov 12, 2026

DayThursday

Rev. Est.$5.24M

NOV

THU

SPLIT RECORD

DATE	TYPE	RATIO
2025-08-28	Reverse	1:20
2019-11-18	Reverse	1:20
2016-03-04	Forward	18:1
2014-10-06	Forward	5:1

PRICE

$6.77 ▼ DOWN 0.00% (−$0.00)

OVERLAYS

About DarioHealth Corp.

https://www.dariohealth.com ↗

DarioHealth Corp. is a digital therapeutics company offering metabolic, musculoskeletal, behavioral health, and chronic condition management solutions, including devices, digital platforms, and coaching across multiple countries.

INDUSTRY

Medical - Specialties

A PRODUCT DARIOHEALTH CORP. IS KNOWN FOR

Dario Blood Glucose Monitoring System

A compact device combining a smart glucose meter, lancing device, and test strips that connects to a smartphone to automatically log readings and deliver real-time insights for diabetes management.